Johnson M, Younan D, Kent ST, Mesa-Frias M, et al. Real-world comparative effectiveness of sotorasib versus docetaxel in second line and beyond among patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer 2024;197:107960.
PMID: 39369609